Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study-Reference-Cited by-同舟云学术

Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study

Published:2013-08 Issue:8 Volume:19 Page:717-724
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Compta Yaroslau,Pereira Joana B.,Ríos Jose,Ibarretxe-Bilbao Naroa,Junqué Carme,Bargalló Núria,Cámara Ana,Buongiorno Mariateresa,Fernández Manel,Pont-Sunyer Claustre,Martí Maria J.

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference39 articles.

1. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years;Hely;Mov Disord,2008

2. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?;Compta;Brain,2011

3. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort;Williams-Gray;Brain,2007

4. Biomarkers and Parkinson's disease;Michell;Brain,2004

5. Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia;Ramirez-Ruiz;J Neurol,2005

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research advancement in fluid biomarkers for Parkinson’s disease;Expert Review of Molecular Diagnostics;2024-09-11

2. Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?;Parkinsonism & Related Disorders;2024-05

3. The association of CSF biomarkers and cognitive decline with choroid plexus volume in early Parkinson's disease;Parkinsonism & Related Disorders;2024-03

4. Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects;Medicina;2024-01-07

5. Plasma Fibronectin is a Prognostic Biomarker of Disability in Parkinson's Disease: A Prospective, Multicenter Cohort Study;2024